Plain-English translation of NCT07558447 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Chemotherapy drugs like paclitaxel, docetaxel, and cisplatin can cause nerve damage — a side effect called chemotherapy-induced peripheral neuropathy — that leads to numbness, tingling, and pain. This study looks for early warning signs in blood samples to predict which patients might develop this nerve damage before symptoms appear, so doctors can potentially intervene sooner.
Right now, doctors can only detect nerve damage after patients start feeling symptoms, when the damage may already be hard to reverse. This research aims to find biological markers in the blood that could warn doctors earlier, giving patients and their doctors a chance to prevent or reduce this painful long-term side effect.
You likely qualify if…
You likely don't qualify if…
You will have blood samples taken at three time points: before your chemotherapy starts, when your chemotherapy ends, and six months after you finish treatment. Each visit also includes standard nerve and physical exams. The study team analyzes your blood samples to look for special particles that may signal nerve injury, comparing these findings with your clinical symptoms and exam results over time.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Italy